Evidence Summary and Comparison of Pre-eclampsia: Seeking Common Ground and Respecting Differences (Part 1)
Abstract：Pre-eclampsia (PE) is not only an important cause of perinatal and maternal mortality [1-2], but also associated with an increased risk of cardiovascular disease (CVD) in mothers and offspring, as well as neurodevelopmental delay in the offspring [3-8]. Its incidence rate is 5% to 7%, and approximately 10 million pregnancies are affected globally each year [9-11]. With the increasing prevalence of obesity, diabetes mellitus (DM), multiple pregnancies, and advanced maternal age, the incidence of PE increased by 25% from 1987 to 2004 [12].
Keywords：pre-eclampsiaguideline recommendationsscreeningevidence-based medicinemanagementpostpartum follow-up
Publication Date：2025-06-02
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 662-666 )